Increase the proportion of adults with diabetes and chronic kidney disease who get ACE inhibitors or ARBs — CKD‑05 Data

Status: Little or no detectable change

Learn more about our data release schedule

Most Recent Data:
49.2 percent (2017-20) *

Target:
58.6 percent *

Desired Direction:
Increase desired

Baseline:
46.2 percent of adults aged 18 years and over with diagnosed diabetes and chronic kidney disease received recommended medical treatment with ACE inhibitors or ARBs in 2013-16 *

* Age adjusted to the year 2000 standard population.

Download CKD-05 data [CSV]

Data Chart
Data Table

Demographic Group

From (year)

To (year)

State

Show disparities data

Show confidence interval (CI) View CI in the chart by hovering over a data point.

Show standard error (SE) View SE in the chart by hovering over a data point.

Confidence Interval (CI) not available Standard Error (SE) not available Confidence Interval (CI) and Standard Error (SE) are not available

#: Standard errors and confidence intervals are not available for this population group.

*: Age adjusted to the year 2000 standard population.

◊: Unless otherwise noted, data represent "percent, 18+ years"

†: Target is not applicable for this demographic group.

DSU: Data do not meet the criteria for statistical reliability, data quality, or confidentiality.

DNA: Data have not been analyzed.

DNC: Data for specific population not collected.

--- : Data are not available.

Learn more about data measurement for this objective